Nivolumab/pembrolizumabVarious toxicities: 9 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1758卷 / 1期

关键词：

D O I：

10.1007/s40278-019-63804-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：258 / 258

相关论文

共 50 条

[31] Nivolumab/pembrolizumabVarious toxicities: 10 case reports
Reactions Weekly, 2022, 1918 (1) : 392 - 392
[32] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1685 (1) : 117 - 117
[33] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1864 (1) : 203 - 203
[34] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 8 case reports
Reactions Weekly, 2020, 1791 (1) : 153 - 153
[35] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1849 (1) : 252 - 252
[36] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 248 - 248
[37] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 10 case reports
Reactions Weekly, 2021, 1840 (1) : 227 - 227
[38] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 20 case reports
Reactions Weekly, 2025, 2042 (1) : 63 - 63
[39] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 18 case reports
Reactions Weekly, 2023, 1957 (1) : 315 - 315
[40] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 29 case reports
Reactions Weekly, 2021, 1859 (1) : 201 - 201

← 1 2 3 4 5 →